Quest Laborato.

81
Strong Buy
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0TNW01017
  • NSEID: QUESTLAB
  • BSEID:
INR
120.65
-6.35 (-5.0%)
BSENSE

Apr 20

BSE+NSE Vol: 56400

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 25.92% vs 33.94% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 2.69% vs 97.32% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 16.21% vs 34.00% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 34.40% vs 100.08% in Mar 2024

Compare Profit and Loss Results of Quest Laborato.
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
103.00
134.00
-31.00
-23.13%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
103.00
134.00
-31.00
-23.13%
Expenditure (Ex Depriciation)
Stock Adjustments
-4.00
-1.00
-3.00
-300.00%
Raw Materials Consumed
83.00
54.00
29.00
53.70%
Power & Fuel Cost
0.00
3.00
-3.00
-100.00%
Employee Cost
4.00
34.00
-30.00
-88.24%
Operating Expenses
0.00
5.00
-5.00
-100.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
4.00
-4.00
-100.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
2.00
1.00
1.00
100.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
87.00
116.00
-29.00
-25.00%
Operating Profit (PBDIT) excl Other Income
15.00
17.00
-2.00
-11.76%
Other Income
4.00
2.00
2.00
100.00%
Operating Profit (PBDIT)
20.00
20.00
0.00
0.00%
Interest
0.00
2.00
-2.00
-100.00%
Profit before Depriciation and Tax
19.00
17.00
2.00
11.76%
Depreciation
0.00
6.00
-6.00
-100.00%
Profit Before Taxation & Exceptional Items
18.00
11.00
7.00
63.64%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
18.00
11.00
7.00
63.64%
Provision for Tax
5.00
3.00
2.00
66.67%
Profit After Tax
13.00
8.00
5.00
62.50%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
14.00
-103.00
117.00
113.59%
Profit Available for appropriations
27.00
-95.00
122.00
128.42%
Appropriations
27.00
-95.00
122.00
128.42%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
8.28
2.28
6.00
263.16%
Profit And Loss - Net Sales
Net Sales 103.97 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 25.92% vs 33.94% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 15.98 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 2.69% vs 97.32% in Mar 2024

Profit And Loss - Interest
Interest 0.91 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 16.21% vs 34.00% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 13.57 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 34.40% vs 100.08% in Mar 2024